Company: DARE
Filing Date: 2025-02-10
Form Type: 8-K
Source: 0001493152-25-005533
Chunk: 0

Company: Dare Bioscience, Inc.
Filing Date: 2025-02-10
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item
7.01 Regulation FD Disclosure.

Exhibit
99.1 to this report is a copy of a corporate presentation dated February 10, 2025, which is incorporated herein by reference. Daré
Bioscience, Inc. (“ Daré” or the “ Company”) intends to use the presentation and its contents during the
BIO CEO & Investor Conference in New York, NY on February 10, 2025 and in various meetings with securities market participants and
others, commencing on February 10, 2025.

The
Company plans to make a copy of the presentation available in the “ Investors” section of its website (https://ir. darebioscience. com),
on the page titled “ Presentations, Events & Webcasts,” under the heading “ Presentations.” Information contained
in, or that can be accessed through, the Company’s website is not incorporated by reference into this report.

The
information in this Item 7.01 and Exhibit 99.1 to this report is being furnished and shall not be deemed to be “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the
liabilities of that section, nor shall such information be deemed to be incorporated by reference into any filing under the Exchange
Act or the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation
by reference language in any such filing, except as the Company expressly sets forth by specific reference in such filing.

Item
9.01 Financial Statements and Exhibits.